• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有贝拉尔迪内利-塞普先天性脂肪代谢障碍的兄弟姐妹:临床见解与挑战

Siblings With Berardinelli-Seip Congenital Lipodystrophy: Clinical Insights and Challenges.

作者信息

Kankipati Sri Meghana, Dumra Surbhi, Thareja Swati, Ishfaq Lyluma, Zargar Mah N, Das Arghadip, Kongala Sreya, Younas Salma

机构信息

Medicine and Surgery, Andhra Medical College, Visakhapatnam, IND.

Medicine, Employees' State Insurance Corporation (ESIC) Medical College and Hospital, Faridabad, IND.

出版信息

Cureus. 2024 Dec 9;16(12):e75434. doi: 10.7759/cureus.75434. eCollection 2024 Dec.

DOI:10.7759/cureus.75434
PMID:39791064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11711709/
Abstract

Berardinelli-Seip congenital lipodystrophy (BSCL), also known as congenital generalized lipodystrophy (CGL), is an exceptionally rare autosomal recessive disorder marked by a significant deficiency of adipose tissue throughout the body. This lack of adipose tissue, normally found beneath the skin and between internal organs, leads to impaired adipocyte formation and fat storage, causing lipids to accumulate in atypical tissues such as muscles and the liver. The extent of adipose tissue loss directly influences the severity of symptoms, which can include a muscular appearance, increased appetite, bone cysts, marrow fat depletion, acromegalic features, severe insulin resistance, skeletal muscle hypertrophy, hypertrophic cardiomyopathy, hepatic steatosis, hepatomegaly, cirrhosis, and intellectual disability. We present a case series of two siblings with BSCL: a nine-year-old boy and his seven-year-old sister, each with unique manifestations of the disorder. The older sibling presented with high-grade fever and right ankle pain, possibly indicative of a calcified deposit, alongside complications such as hyperglycemia (managed without insulin) and moderate pulmonary arterial hypertension (PAH) with tricuspid regurgitation (TR). The younger sibling displayed similar metabolic and cardiovascular complications, including hepatomegaly and early signs of cardiac involvement. Both cases required comprehensive evaluations, revealing anemia, thrombocytopenia, elevated leukocyte count, and high C-reactive protein (CRP) levels. The children were managed with high-potency antibiotics, leading to a marked improvement in their overall conditions. These cases demonstrate the broad spectrum of clinical manifestations associated with BSCL and highlight the importance of a multidisciplinary approach for effective management. Although limited by the small sample size, this case series shows the importance of a multidisciplinary approach in addressing the complex and overlapping symptoms of BSCL, which often mimic more common conditions. Increased awareness among healthcare providers is crucial for ensuring timely diagnosis and appropriate intervention, particularly in pediatric patients.

摘要

贝拉尔迪内利 - 塞普先天性脂肪营养不良(BSCL),也称为先天性全身性脂肪营养不良(CGL),是一种极为罕见的常染色体隐性疾病,其特征是全身脂肪组织严重缺乏。这种通常存在于皮肤下方和内脏器官之间的脂肪组织缺失,导致脂肪细胞形成和脂肪储存受损,使脂质在非典型组织如肌肉和肝脏中积聚。脂肪组织缺失的程度直接影响症状的严重程度,症状可能包括肌肉外观、食欲增加、骨囊肿、骨髓脂肪消耗、肢端肥大症特征、严重胰岛素抵抗、骨骼肌肥大、肥厚型心肌病、肝脂肪变性、肝肿大、肝硬化和智力残疾。我们报告了一例患有BSCL的两兄弟姐妹病例系列:一名9岁男孩和他7岁的妹妹,他们各自有该疾病的独特表现。年长一点的兄弟姐妹出现高热和右踝疼痛,可能提示有钙化沉积物,同时伴有高血糖(无需胰岛素治疗)和中度肺动脉高压(PAH)伴三尖瓣反流(TR)等并发症。年幼一点的兄弟姐妹表现出类似的代谢和心血管并发症,包括肝肿大和心脏受累的早期迹象。两例均需要全面评估,结果显示有贫血、血小板减少、白细胞计数升高和高C反应蛋白(CRP)水平。这两个孩子接受了强效抗生素治疗,整体状况有显著改善。这些病例证明了与BSCL相关的广泛临床表现,并强调了多学科方法对有效管理的重要性。尽管受样本量小的限制,但这个病例系列显示了多学科方法在解决BSCL复杂且重叠的症状(这些症状常常类似更常见的病症)方面的重要性。提高医疗服务提供者的认识对于确保及时诊断和适当干预至关重要,尤其是在儿科患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1762/11711709/c575d5c989b7/cureus-0016-00000075434-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1762/11711709/a860edb7cf44/cureus-0016-00000075434-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1762/11711709/c575d5c989b7/cureus-0016-00000075434-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1762/11711709/a860edb7cf44/cureus-0016-00000075434-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1762/11711709/c575d5c989b7/cureus-0016-00000075434-i02.jpg

相似文献

1
Siblings With Berardinelli-Seip Congenital Lipodystrophy: Clinical Insights and Challenges.患有贝拉尔迪内利-塞普先天性脂肪代谢障碍的兄弟姐妹:临床见解与挑战
Cureus. 2024 Dec 9;16(12):e75434. doi: 10.7759/cureus.75434. eCollection 2024 Dec.
2
Berardinelli Seip Syndrome: A rare case report.伯-塞二氏综合征:一例罕见病例报告。
J Pak Med Assoc. 2022 May;72(5):969-971. doi: 10.47391/JPMA.3182.
3
Berardinelli-Seip Congenital Lipodystrophy Discovered Following a STEMI Event.在ST段抬高型心肌梗死事件后发现的贝拉尔迪内利-塞普先天性脂肪营养不良
Eur J Case Rep Intern Med. 2022 Dec 14;9(12):003658. doi: 10.12890/2022_003658. eCollection 2022.
4
Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps.贝拉尔迪内利-塞普先天性脂肪代谢障碍:一种常染色体隐性疾病,罕见地伴有十二指肠结肠息肉。
J Pediatr Endocrinol Metab. 2014 Sep;27(9-10):989-91. doi: 10.1515/jpem-2013-0399.
5
Berardinelli-Seip congenital lipodystrophy in two siblings.两例患贝拉尔迪内利-塞普先天性脂肪代谢障碍的同胞。
Indian Dermatol Online J. 2014 Nov;5(Suppl 1):S20-2. doi: 10.4103/2229-5178.144511.
6
Pathology of congenital generalized lipodystrophy in Agpat2-/- mice.Agpat2-/- 小鼠先天性全身性脂肪营养不良的病理学研究。
Vet Pathol. 2011 May;48(3):642-54. doi: 10.1177/0300985810383870. Epub 2010 Nov 4.
7
Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction.Berardinelli-Seip 先天性脂肪营养不良的基因型-表型相关性及新候选基因预测。
Orphanet J Rare Dis. 2020 Apr 29;15(1):108. doi: 10.1186/s13023-020-01383-y.
8
Berardinelli-Seip Congenital Generalised Lipodystrophy.贝拉尔迪内利-塞普先天性全身脂肪营养不良
J Coll Physicians Surg Pak. 2018 May;28(5):406-408. doi: 10.29271/jcpsp.2018.05.406.
9
Berardinelli-Seip Congenital Lipodystrophy - A Case Report and Review of Literature.贝拉尔迪内利-塞普先天性脂肪代谢障碍——一例病例报告及文献综述
J Coll Physicians Surg Pak. 2022 Jun;32(6):817-819. doi: 10.29271/jcpsp.2022.06.817.
10
A case of Berardinelli-Seip syndrome presenting with cirrhosis.一例以肝硬化为表现的贝拉尔迪内利-塞普综合征病例。
J R Coll Physicians Edinb. 2013;43(4):309-11. doi: 10.4997/JRCPE.2013.406.

本文引用的文献

1
Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa.中东和北非地区先天性全身性脂肪营养不良大患者队列的疾病特征分析。
Orphanet J Rare Dis. 2024 Mar 13;19(1):118. doi: 10.1186/s13023-024-03084-2.
2
A new mutation in the gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature.两例先天性全身性脂肪营养不良 4 型患儿基因新突变:病例报告及文献复习
Front Endocrinol (Lausanne). 2023 Jul 12;14:1212729. doi: 10.3389/fendo.2023.1212729. eCollection 2023.
3
Identifying congenital generalized lipodystrophy using deep learning-DEEPLIPO.
利用深度学习技术 DEEPLIPO 对先天性全身性脂肪营养不良进行识别。
Sci Rep. 2023 Feb 7;13(1):2176. doi: 10.1038/s41598-023-27987-5.
4
Treatment Options for Lipodystrophy in Children.儿童脂肪营养不良的治疗选择。
Front Endocrinol (Lausanne). 2022 May 4;13:879979. doi: 10.3389/fendo.2022.879979. eCollection 2022.
5
Lipodystrophies in Children.儿童脂肪营养不良症。
Horm Res Paediatr. 2022;95(4):305-320. doi: 10.1159/000522620. Epub 2022 Feb 21.
6
Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction.Berardinelli-Seip 先天性脂肪营养不良的基因型-表型相关性及新候选基因预测。
Orphanet J Rare Dis. 2020 Apr 29;15(1):108. doi: 10.1186/s13023-020-01383-y.
7
Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease.先天性全身性脂肪萎缩症(Berardinelli-Seip 综合征)1 型:描述显示疾病高度异质性表现的新型纯合变异体。
Front Endocrinol (Lausanne). 2020 Feb 14;11:39. doi: 10.3389/fendo.2020.00039. eCollection 2020.
8
Changes in redox and endoplasmic reticulum homeostasis are related to congenital generalized lipodystrophy type 2.氧化还原和内质网稳态的变化与 2 型先天性全身性脂肪营养不良有关。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Apr;1865(4):158610. doi: 10.1016/j.bbalip.2020.158610. Epub 2020 Jan 7.
9
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy. metreleptin 治疗部分脂肪营养不良患者的长期疗效和安全性。
Endocrine. 2019 Jun;64(3):500-511. doi: 10.1007/s12020-019-01862-8. Epub 2019 Feb 25.
10
Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer.关联注册中心:通过语义网层连接罕见病患者注册中心。
Biomed Res Int. 2017;2017:8327980. doi: 10.1155/2017/8327980. Epub 2017 Oct 29.